… One large randomised, parallel double‐blind controlled trial comparing ethosuximide,
lamotrigine and sodium valproate in 453 children with newly diagnosed childhood absence …

… ethosuximide, lamotrigine and valproate are commonly used to treat children and adolescents
with absence seizures… from one trial that lamotrigine has an effect on seizures, but the trial …

… ethosuximide, lamotrigine and valproate are commonly used to treat children and adolescents
with absence seizures… from one trial that lamotrigine has an effect on seizures, but the trial …

… lamotrigine with other drugs and/or placebo for the treatment of absence seizures in children
and adolescents … than valproate and ethosuximide at reducing seizures in children with …

… ethosuximide (ESX), valproic acid (VPA), and lamotrigine (LTG) as initial monotherapies for
patients with newly diagnosed childhood absence epilepsy… with childhood absence epilepsy …

… The treatment of choice for CAE with absence seizures only is ethosuximide. Valproic acid
and lamotrigine are also … during adolescence, with generalized tonic seizures, myoclonic …

… ethosuximide, valproic acid, and lamotrigine in children with newly diagnosed childhood
absence epilepsy… Drug doses were incrementally increased until the child was free of seizures, …

… To summarize, ethosuximide, lamotrigine and valproate are the principal antiepileptic
drugs used to treat children and adolescents with childhood absence epilepsy [30]. …

… were with no significant difference compared with valproic acid and ethosuximide. Conclusion
Lamotrigine monotherapy was effective for absence seizures in children and adolescents …

… of syrup of sodium valproate, ethosuximide, and lamotrigine, … 600 mg syrup sodium valproate
and 150 mg lamotrigine. On video … Forty two children and young adolescents completed the …